Reduces risk of MI, stroke, & unstable angina requiring hospitalization in adults w/ established CV disease. As an adjunct to diet, alone or in combination w/ other lipid-lowering therapies (eg, statins, ezetimibe), for the treatment of adults w/ primary hyperlipidemia to reduce LDL-C.
SC Starting dose: 75 mg once every 2 wk. Alternative starting dose for patients who prefer less frequent dosing is 300 mg once every 4 wk (mthly). Max: 150 mg every 2 wk.
Sign Out
